Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38.07 USD | -2.48% | -0.78% | -17.35% |
Financials (USD)
Sales 2024 * | 1.88M | Sales 2025 * | 9.39M | Capitalization | 2.87B |
---|---|---|---|---|---|
Net income 2024 * | -222M | Net income 2025 * | -264M | EV / Sales 2024 * | 1,145 x |
Net cash position 2024 * | 727M | Net cash position 2025 * | 650M | EV / Sales 2025 * | 237 x |
P/E ratio 2024 * |
-13
x | P/E ratio 2025 * |
-11.6
x | Employees | 255 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.44% |
Latest transcript on Xenon Pharmaceuticals Inc.
1 day | -2.48% | ||
1 week | -0.78% | ||
1 month | -10.40% | ||
3 months | -18.72% | ||
6 months | +3.45% | ||
Current year | -17.35% |
Managers | Title | Age | Since |
---|---|---|---|
Ian Mortimer
CEO | Chief Executive Officer | 48 | 13-10-20 |
Simon Pimstone
FOU | Founder | 56 | 96-11-04 |
Sherry Aulin
DFI | Director of Finance/CFO | 41 | 10-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Clarence Machado
BRD | Director/Board Member | 60 | 20-11-04 |
Mohammad Azab
BRD | Director/Board Member | 68 | 03-09-30 |
Justin Gover
BRD | Director/Board Member | 53 | 23-08-07 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.96% | 14 M€ | -5.07% | ||
0.22% | 0 M€ | 0.00% | - | |
0.22% | 0 M€ | 0.00% | - | |
0.20% | 12 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 38.07 | -2.48% | 778,149 |
24-05-30 | 39.04 | +1.96% | 304,956 |
24-05-29 | 38.29 | -0.83% | 264,337 |
24-05-28 | 38.61 | +0.63% | 331,221 |
24-05-24 | 38.37 | -0.23% | 193,372 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.35% | 2.87B | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- XENE Stock